Acute Decompensated Heart Failure Secondary to Exogenous Triiodothyronine Use in a Young Non-athlete Weightlifter

Abstract

Heart failure (HF) is a common cardiovascular disorder and is associated with increased morbidity and mortality. HF is usually detected in the elderly population, in particular, in patients with coronary artery disease, valvular disease, myocarditis, and hypertension. Acute decompensated HF in previously healthy young patients should raise suspicion for other rare etiologies. We report a case of a 28-year-old male presenting with acutely decompensated HF secondary to performance-enhancing drugs (PED). The use of non-regulated, non-approved PED has become a world-wide health problem with patients often unaware of the potentially serious and fatal side effects.

Algumas recomendações para atletas jovens corredores de 400 metros com problemas no sistema cardiovascular.

“…Por outro lado, o Ecocardiograma oferece a possibilidade de detectar anomalias mais profundas como hipertrofia nunca antes detectadas (Daher et al, 2019), algumas cardiopatias com características determinantes para suspensão da prática, mas é restrito pelo seu alto custo e acessibilidade para a maioria dos atletas, sendo enviado apenas em casos de detecção de problemas reais (Daher et al, 2019).…”